FDA Warns Patients, Providers Against Unauthorized Diabetes Devices

FDA on Friday (May 17) warned patients and health care providers against using diabetes management systems that use unauthorized continuous glucose monitoring systems (CGMs), insulin pumps or automated insulin dosing (AID) systems to monitor a patient’s glucose levels and administer insulin doses. The warning came after FDA received a report that a patient suffered an insulin overdose from the unauthorized device they were using in tandem with an FDA authorized glucose sensor, the agency explained. The warning also comes three...